
Felix Hoffstaedter
Articles
-
Jan 28, 2024 |
nature.com | Felix Hoffstaedter |Birgit Derntl |Renaud Jardri |Kang Hee Sim |Juan Zhou |Dominique I. Pelzer
AbstractA common hypothesis on the etiopathology of schizophrenia is that the failure of segregation of right from left hemisphere functions is a core deficit in psychosis. It has even been proposed that schizophrenia symptoms in general may reflect a hemispheric ‘dominance failure’ for language and that the corresponding predisposition is genetic.
-
Dec 23, 2023 |
biorxiv.org | Marvin Petersen |Felix Hoffstaedter |Felix L. Naegele |Carola Mayer
AbstractThe link between metabolic syndrome (MetS) and neurodegenerative as well cerebrovascular conditions holds substantial implications for brain health in at-risk populations. This study elucidates the complex relationship between MetS and brain health by conducting a comprehensive examination of cardiometabolic risk factors, cortical morphology, and cognitive function in 40,087 individuals.
-
Oct 12, 2023 |
biorxiv.org | Marvin Petersen |Felix Hoffstaedter |Felix L. Naegele |Carola Mayer
AbstractThe link between metabolic syndrome (MetS) and neurodegenerative as well cerebrovascular conditions holds substantial implications for brain health in at-risk populations. This study elucidates the complex relationship between metabolic syndrome (MetS) and brain health by conducting a comprehensive examination of cardiometabolic risk factors, cortical morphology, and cognitive function in 40,087 individuals.
-
Feb 22, 2023 |
biorxiv.org | Marvin Petersen |Felix Hoffstaedter |Felix L. Naegele |Carola Mayer
AbstractMetabolic syndrome (MetS) describes the clustered prevalence of abdominal obesity, arterial hypertension, dyslipidemia and insulin resistance, collectively promoting cerebrovascular disease. Although this risk factor complex causes a substantial health burden in modern societies, its neural underpinnings remain elusive.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →